Related Experiment Video
Updated: Jun 7, 2025

Assessing Bacterial Invasion of Cardiac Cells in Culture and Heart Colonization in Infected Mice Using Listeria monocytogenes
Published on: May 27, 2015
Musculoskeletal infections associated with Nocardia species: a case series
Ryan B Khodadadi1, Jack W McHugh1, Supavit Chesdachai1
1Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
Background: Nocardia is an uncommon pathogen that has been reported to infect musculoskeletal structures. However, studies are largely limited to case reports, and little is known regarding management and outcomes of these infections. Methods: We performed a multicenter retrospective cohort study of adults with culture-confirmed musculoskeletal Nocardia infections at three Mayo Clinic centers in Arizona, Florida, and Minnesota from November 2011 through April 2022. Results: Nine cases of Nocardia musculoskeletal infection were identified. Seven (78 %) occurred in men, and the median age was 57.3 years (range 32.6-79.0). Specific infections included native joint septic arthritis with or without associated osteomyelitis ( ), hardware-associated infection ( ), sternal osteomyelitis ( ), pyomyositis ( ), bursitis ( ), and tenosynovitis ( ). Three cases (33 %) were associated with disseminated disease, all three occurring in solid organ transplant recipients. Surgical intervention was performed in all but the bursitis case. Length of treatment varied from 21 d for tenosynovitis to 467 d for osteomyelitis. The 1-year mortality was 22 %, and all fatal cases involved disseminated disease. Conclusion: Patients with localized nocardiosis affecting musculoskeletal structures generally have good outcomes, as opposed to those with disseminated infection. Management often required operative intervention, with one patient experiencing recurrence within 1 year.
Insights
Musculoskeletal Nocardia infections are rare but can be serious. Localized infections often resolve well with treatment, but disseminated Nocardia infections, especially in transplant recipients, carry a high mortality risk.
Area of Science:
- Infectious Diseases
- Musculoskeletal Infections
- Medical Microbiology
Background:
- Nocardia species are infrequent causes of musculoskeletal infections.
- Existing literature primarily consists of case reports, limiting understanding of management and outcomes.
- Further research is needed to elucidate effective treatment strategies and prognosis.
Purpose of the Study:
- To investigate the clinical characteristics, management, and outcomes of musculoskeletal Nocardia infections.
- To identify risk factors and prognostic indicators for these infections.
- To provide insights into the effective treatment of Nocardia musculoskeletal infections.
Main Methods:
- A multicenter retrospective cohort study was conducted.
- Adult patients with culture-confirmed musculoskeletal Nocardia infections were included.
- Data were collected from November 2011 to April 2022 across three Mayo Clinic centers.
Main Results:
- Nine cases of musculoskeletal Nocardia infection were identified, predominantly in men (78%).
- Infections varied, including septic arthritis, osteomyelitis, and pyomyositis. Disseminated disease occurred in 33% of cases, notably in solid organ transplant recipients.
- Mortality was 22% at 1 year, exclusively in patients with disseminated Nocardia infections.
Conclusions:
- Localized musculoskeletal Nocardia infections generally have favorable outcomes.
- Disseminated Nocardia infections are associated with significantly higher mortality.
- Surgical intervention is frequently required for management, and recurrence is possible.
Related Concept Videos
Endocarditis I: Introduction
Myocarditis I: Introduction
Myocarditis II: Clinical features and Diagnostic Tests
Endocarditis II: Clinical features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management

